Development of a Novel Dual CCR5-Dependent and CXCR4-Dependent Cell-Cell Fusion Assay System with Inducible gp160 Expression
Open Access
- 1 February 2006
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 11 (1), 65-74
- https://doi.org/10.1177/1087057105282959
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Enfuvirtide: the first HIV fusion inhibitorExpert Opinion on Pharmacotherapy, 2005
- Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120BMC Neuroscience, 2005
- The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry InhibitorMolecular Pharmacology, 2005
- The Discovery of the CCR5 Receptor Antagonist, UK-427,857, A New Agent for the Treatment of HIV Infection and AIDSProgress in Medicinal Chemistry, 2005
- Development and Automation of a 384-Well Cell Fusion Assay to Identify Inhibitors of CCR5/CD4-Mediated HIV Virus EntrySLAS Discovery, 2004
- Prospects of HIV‐1 entry inhibitors as novel therapeuticsReviews in Medical Virology, 2004
- Development of a Novel High-Throughput Surrogate Assay to Measure HIV Envelope/CCR5/CD4-Mediated Viral/Cell Fusion Using BacMam Baculovirus TechnologySLAS Discovery, 2003
- Development of a Safe and Rapid Neutralization Assay Using Murine Leukemia Virus Pseudotyped with HIV Type 1 Envelope Glycoprotein Lacking the Cytoplasmic DomainAIDS Research and Human Retroviruses, 2001
- Mechanisms of Viral Membrane Fusion and Its InhibitionAnnual Review of Biochemistry, 2001
- New Reporter Cell Lines to Study Macrophage-Tropic HIV Envelope Protein-Mediated Cell-Cell FusionAIDS Research and Human Retroviruses, 1999